Navigation Links
United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
Date:7/28/2011

t Reports on Form 8-K.  We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of July 28, 2011, and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. [uthr-g]

Remodulin and Tyvaso are registered trademarks of United Therapeutics Corporation.

Adcirca is a registered trademark of Eli Lilly and Company.

UNITED THERAPEUTICS CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS(In thousands, except per share data)Three Months EndedJune 30,Six Months EndedJune 30,2011201020112010(Unaudited)(Unaudited)Revenues:Net product sales

$

183,546$

134,439$

345,764$

260,071License fees

205282499564Total revenues

183,751134,721346,263260,635Operating expenses:Research and development

24,24028,58771,94763,055Selling, general and administrative

23,85629,65482,11875,106Cost of product sales

21,16215,26140,90028,984Total operating expenses

69,25873,502194,965167,145Operating income

114,49361,219151,29893,490Other (expense) income:Interest income

8398021,5041,746Interest expense

(5,431)(4,759)(10,841)(9,446)Equity loss in affiliate

(30)(44)(67)(91)Other, net

(257)93(1,023)318Total other (expense) income, net

(4,879)(3,908)(10,427)(7,473)Income from continuing operations before income taxes

109,61457,311140,87186,017Income tax expense

(35,723)(19,345)(47,622)(29,106)Income from continuing operations

73,89137,96693,24956,911Discontinued operations:(Loss) income from discontinued operations, net of tax

—(259)76(275)Loss on disposal of discontinued operations, net of tax

——(3,044)—Loss from discontinued operations

—(259)(2,968)(275)N
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
2. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
3. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
4. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
5. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
6. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
7. United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
8. United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
9. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
10. United Therapeutics Corporation to Announce Second Quarter 2010 Financial Results Before Market Open on Wednesday, July 28, 2010
11. Report Details How States Respond to Citizens United Decision
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013 BioTrends ... and advisory firms for specialized biopharmaceutical issues, finds ... and infectious disease specialists reported that in the ... (e.g., intentionally delaying treatment) in anticipation of the ... six months ago, when only 6 percent reported ...
(Date:5/23/2013)... BETHESDA, Md. , May 23, 2013 ... a biotechnology company developing DCVax ® personalized immune ... will use its exhibit at this year,s American Society ... to highlight its leadership role in immune ... The ASCO annual meeting is the pre-eminent conference ...
(Date:5/23/2013)... , May 23, 2013  Verenium Corporation (Nasdaq: ... on the development and commercialization of high-performance enzymes, today ... Financial Officer, will present at two upcoming conferences. ... will present at the Second Annual Marcum LLP Microcap ... Hyatt Hotel in New York City.  The presentation is ...
(Date:5/23/2013)... May 23, 2013 SynCardia Systems, Inc. ... only FDA, Health Canada and CE (Europe) approved Total ... in Scotland, which boasts more than 380,000 visitors annually, ... powered by the Freedom® portable driver as part ... most advanced exhibitions of its kind. , “BodyWorks ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
... Waukesha, Wis. -- Prodesse, Inc. ... and that it has completed a major process improvement ... a group of its core investors, plus three new ... The offering is composed of a debt instrument convertible ...
... Place , the University of Wisconsin-Madison's astronomy outreach center, will ... Sunday, Aug. 28. Opening week activities continue through Thursday, Sept. ... , ,"We had pretty much outgrown our other place where ... programming, our attendance has increased steadily every year, and our ...
... every biologist knows that men and women truly are different. ... those differences come to the fore: around 80 percent of ... behaviors also differ greatly between the sexes - just about ... ,Early in human development, critical brain proteins known as steroid ...
Cached Biology Technology:Prodesse gets new funding; improves flu assay 2Space Place opens new astronomy center 2Gender hormones may lend to social disorder therapies 2
(Date:5/22/2013)... U.S. Forest Service scientists are part of "Landscapes ... the TKF Foundation, will examine how collaborative planning and ... from tragedy. , The TKF Foundation announced today that ... for grant funding. In addition to research on the ... and resiliency, the 3-year, $585,000 grant will contribute to ...
(Date:5/22/2013)... 22, 2013)The omega 3 fatty acids in fish oil ... much so that the American Heart Association currently recommends ... particularly fatty varieties rich in omega 3s. However, the ... In a new study, scientists led by Jason R. ... phenomenon by providing evidence that fish oil might specifically ...
(Date:5/22/2013)... provide important new details on how climate change will ... 21 in the Journal of Animal Ecology . ... predictions and informing policymakers of how species are likely ... "There is a growing recognition among biologists that climate ... and that this is going to have very important ...
Breaking Biology News(10 mins):'Landscapes of Resilience' to study how people use nature as a source of recovery 2Fish oil may help the heart beat mental stress 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... a friend or relative won $100 and then offered you ... answer would seem to be, sure, why not? "But human ... professor of physics at Virginia Tech and director of the ... According to research conducted over the last three ...
... one year anniversary of the Deepwater Horizon oil spill that ... of many residents of coastal Louisiana, it,s difficult to put ... the environmental impacts have thus far not been as pervasive ... is still simply too early to tell. However, dependence upon ...
... the Polar Regions and the deep sea is the ... project, involving over 200 international scientists. The CAREX ... Environments) roadmap outlines priorities for future research into life ... Life has evolved thousands of strategies to adapt ...
Cached Biology News:Functional MRI shows how mindfulness meditation changes decision-making process 2Functional MRI shows how mindfulness meditation changes decision-making process 3Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 2Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 3Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 4Shades of gray: LSU researcher studies South Louisiana's historical ties to the oil industry 5Life in extreme environments paves the way for international collaboration 2
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
... Solid phase reagent for ... Easy & unique water ... with detergents and chaotropes; ... recover non-envelop viruses while ...
Integrins Sampler Kit 10g each...
PKC Sampler Kit 10 mu g each...
Biology Products: